Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

PaperCitations, authors & open-access status

Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 298 citations, 2007 year and closed oa status.

298
Citations
2007
Year
closed
OA Status

Related on ScholarIQ

Joseph O. Moore
Author
Journal of Clinical Oncology
Journal
Chronic Lymphocytic Leukemia Research
Topic
Chronic Lymphocytic Leukemia Research
Topic
Immunodeficiency and Autoimmune Disorders
Topic
Glycogen Storage Diseases and Myoclonus
Topic
470M+ articles · free account